Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINOMAB BIO-B

1.800
+0.0301.69%
Volume:11.23M
Turnover:20.17M
Market Cap:2.50B
PE:-9.53
High:1.820
Open:1.770
Low:1.750
Close:1.770
52wk High:3.760
52wk Low:0.800
Shares:1.39B
HK Float Shares:1.39B
Volume Ratio:2.25
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.189
ROE:-55.49%
ROA:-9.91%
PB:9.37
PE(LYR):-9.53
PS:398.12

Loading ...

Hong Kong Stock Market Preview | International Gold Prices Reach New Historic High, Powell Signals Potential End to Balance Sheet Reduction

Stock News
·
Oct 15

SinoMab BioScience Doses First Group of Patients in Atopic Dermatitis Drug Study

MT Newswires Live
·
Oct 14

SINOMAB BIO-B (03681): SM17 Subcutaneous Injection Bridging Study in China Completes First Cohort Dosing in Healthy Subjects

Stock News
·
Oct 14

SinoMab BioScience Announces Successful Dosing of First Cohort in Bridging Study of Subcutaneous SM17 in China

Reuters
·
Oct 14

SINOMAB BIO-B (03681): Lai Weiqi Appointed as Company Secretary

Stock News
·
Oct 08

SinoMab BioScience Appoints Lai Florence Wai Ki as New Company Secretary Replacing Chow Yuk Yin Ivy

Reuters
·
Oct 08

Core Pipeline Breakthroughs Highlight Autoimmune Expertise as SINOMAB BIO-B (03681) Drives Innovation-Led Growth

Stock News
·
Sep 04

Hong Kong Stock Alert | SINOMAB BIO-B (03681) Surges Over 15% on Significant Clinical Trial and Pipeline Development Progress, First-Half Revenue Reaches RMB 9.802 Million

Stock News
·
Sep 03

SINOMAB BIO-B (03681) Reports Interim Results with RMB 32.74 Million R&D Costs as Two Core Drug Pipelines Achieve Breakthrough Progress

Stock News
·
Aug 29

SinoMab BioScience H1 Net Income RMB -49.8 Million

THOMSON REUTERS
·
Aug 29

SINOMAB BIO-B (03681) Completes Issuance of 24.97 Million Subscription Shares

Stock News
·
Aug 29

SINOMAB BIO-B (03681) Issues 157 Million Subscription Shares on August 15 Under Subscription Agreement

Stock News
·
Aug 15

Hong Kong Stock Movement | SINOMAB BIO-B (03681) Surges Over 11% Intraday Following Strategic Partnership with Sun Yat-sen University Hong Kong Institute for Advanced Study in Biomedical Innovation and R&D

Stock News
·
Aug 15

SinoMab Signs 3-Year Biomedicine R&D Deal with Hong Kong Institute

MT Newswires Live
·
Aug 13

SinoMab BioScience Ltd. Announces New Share Option Grant for Employees and Service Providers

Reuters
·
Jul 24

SinoMab BioScience to Sell HK$370 Million Worth of Shares; Stock Jumps 8%

MT Newswires Live
·
Jul 23

BRIEF-Sinomab Bioscience To Issue Aggregate Of 182.1 MLN New Shares At HK$2.03 Per Subscription Share

Reuters
·
Jul 22

Hong Kong Stocks Movement: SINOMAB BIO-B (03681) Soars Over 18% After Withdrawing RA Treatment Application; Drug Shows SLE Potential

Deep News
·
Jul 16

SINOMAB BIO-B (03681) Surges Over 18% After Withdrawing Sucirasertib RA Application, Retains SLE Treatment Potential

Stock Track
·
Jul 16

BRIEF-SinoMab Bioscience Withdraws Biologics License Application

Reuters
·
Jul 14